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An insulin-stimulating protein was isolated from human plasma by a procedure involving Sephadex G-100 
chromatography and reverse-phase HPLC. The isolated material gave a single band on SDS-polyacryl- 
amide gel electrophoresis. This protein itself had no insulin-like activity, but enhanced fatty acid synthesis 
from glucose in rat adipose tissue explants in the presence of suboptimal concentrations of insulin. It also 
stimulated the effect of insulin on CO, liberation from glucose by isolated rat adipocytes and increased the 
maximal response to insulin. 
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l_ INTRODUCTION 2. MATERI,\LS AND METHODS 
It is well accepted that the action of insulin is 
greatly influenced by alterations in sensitivity of 
responsiveness of target tissues to the hormone [I]. 
However, little is known about the m~hanisms of 
these phenomena. There are reports that insulin 
fragments [2-41 or fragments from human growth 
hormone [5] potentiate the action of insulin in 
vitro. Previously [6], we found that treatment of 
bovine serum albumin with trypsin produced an 
insulin-stimulating peptide and we determined the 
structure of this peptide. These findings suggest 
the presence of a substance(s) that controls the ac- 
tion of insulin of target tissues in vivo. Subse- 
quently, we isolated a protein from human plasma 
that stimulates the action of insulin on adipose 
tissue systems in vitro. Here, we report the isola- 
tion and some biological activities of this protein 
from human plasma. 
2.1, Assay of H-ISP activity 
H-ISP activity was assayed by measuring fatty 
acid synthesis and CO2 production from glucose in 
rat adipose tissue explants and isolated fat cells, 
respectively, in the presence of suboptimal concen- 
trations of insulin (porcine, crystallized, 24.3 
IU/mg, Sigma). 
For fatty acid synthesis, IO explants (total wet 
wt, 8-10 mg) were prepared from epidid~al fat 
pads of male Wistar rats, weighing about 200 g, 
that had been fed ad libitum. The explants were 
cultured on siliconized lens paper [7] in a sterile 
petri dish containing 3 ml of medium 199 supple- 
mented with 0.05 ,&i/mI [U-‘4C]glucose (Radio- 
chemical Centre), 1.5 mglml NaHCO3 and an- 
tibiotics. After incubation for 20 h at 37°C under 
3% CO2 in air, unless otherwise specified, the ex- 
plants were weighed and hydrolyzed in 1 ml of 2 N 
KOH in 50% ethanol for 2 h at IOO’C. Fatty acids 
were extracted from the acidic hydrolyzate with 3 
ml of petroieum ether 181. This assay method was 
used for the purification of H-ISP. 
Abbreviations: H-ISP, insulin-stimulating protein from 
human plasma 
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Fatty acid synthesis CO, production 
Production of COZ was assayed by measuring 
conversion of [l-14C]-glucose to 14C02 by rat 
adipocytes, essentially as described [9]. Reaction 
mixtures contained (0.75-l) x IO6 cells/ml, [1-14C]- 
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glucose (0.2 mM, 0.3 &i/ml) and 10 mg/ml 
crystallized bovine serum albumin (Sigma) in a 
total volume of 0.4 ml Krebs-Ringer phosphate 
buffer. r4C02 was collected and counted as de- 
scribed [lo]. 
2.2. Analytical gel electrophoresis 
Analytical gel electrophoresis was performed as 
described in [ 111, except that the final concentra- 
tions of acrylamide and bisacrylamide were 20.86 
and 0.096%, respectively. 
3. RESULTS 
3.1. Purification of H-ISP 
Chilled ethanol (2 1) was added to 1 1 human 
plasma with stirring for 30 min in the cold. Insolu- 
ble material was removed by centrifugation at 
10000 x g for 30 min, and the resulting superna- 
tant concentrated to about 300 ml at 37°C under 
reduced pressure. The concentrated supernatant 
was shaken with an equal volume of chloroform, 
and the aqueous phase concentrated to about 200 
ml under reduced pressure, dialyzed overnight 
against two changes of distilled water (5 1 each) in 
a Spectrapor 3 (Spectrum Medical; 3500 Da cutoff) 
and lyophilized. 
The dried material (about 200 mg protein) was 
dissolved in 15 ml 10 mM Tris-HCl buffer contain- 
ing 0.1 M NaCl (pH 7.40) and passed through a 
Sephadex G-100 column (4.4 x 90 cm) in the same 
buffer at a flow rate of 20 ml/h. Fractions contain- 
ing H-ISP activity were pooled, dialyzed, and 
lyophilized. 
The lyophilized material was dissolved in dis- 
tilled water and fractionated on a TSK gel ODS- 
120A column (78x300 mm, Toyo Soda) with 
0.1% trifluoroacetic acid (solvent A) as the mobile 
phase, and 90% acetonitrile containing 0.1% tri- 
fluoroacetic acid (solvent B) as a mobile-phase 
modifier. Elution was carried out with a linear gra- 
dient of solvent B as follows: 53% B for 20 min, 
53-66% B in 30 min and 66-100% B in 10 min at 
a flow rate of 1 ml/min at 22-25°C. H-ISP activity 
was eluted from the column after 42-50 min under 
these conditions. Final purification was achieved 
on a Hi-Pore RP 304 column (4.6 x 250 mm, Bio- 
Rad) with solvent A as the mobile phase, and 
solvent B as the mobile-phase modifier. Elution 
was effected with a linear gradient of solvent B as 
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Fig. 1. HPLC of H-ISP on a Hi-Pore RP-304 column. 
The horizontal bar indicates the fractions of H-ISP 
pooled and used for further experiments. The inset 
shows the SDS-polyacrylamide gel electrophoretic pro- 
file of purified H-ISP. 
follows: O-40070 B in 5 min, 40-60% B in 40 min 
and 60-100% B in 5 min at a flow rate of 1 ml/min 
at 22-25°C (fig.1). As shown (fig.1, inset) the 
purified material gave a single band with an Mr of 
about 16000 on SDS-polyacrylamide gel elec- 
trophoresis. The isoelectric point of H-ISP was 
estimated to be about 4.7. Purified H-ISP was 
stable on heating at 60°C for 10 min and no loss 
of activity was observed on storage as an aqueous 
solution for at least 6 months at -20°C or for 24 
h at 4°C at pH 2.0. 
3.2. Biological activities of H-ISP 
As can be seen from fig.2A, H-ISP markedly 
stimulated the action of insulin added at a subop- 
timal concentration (0.2 mu/ml) on fatty acid syn- 
thesis in the adipose tissue explant system. Stimul- 
ation was maximal with more than 15 fig/ml of H- 
ISP under the experimental conditions. H-ISP 
alone had no insulin-like activity in the concentra- 
tion range tested (fig.%A). Next, the effect of H- 
ISP was tested as a function of the concentration 
of insulin. H-ISP shifted the concentration-re- 
sponse curve of insulin-dependent fatty acid syn- 
thesis to the left (fig.2B). 
As shown in table 1, H-ISP also stimulated CO2 
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Fig.2. (A) Effect of the concentration of H-ISP on fatty 
acid synthesis from glucose in the presence of insulin. 
Adipose tissue explants were incubated at 37°C for 20 h 
with the indicated concentrations of H-ISP in the 
absence (0) or presence (0) of insulin (0.2 mU/ml). 
Values are means for duplicate determinations in two 
separate experiments. (B) Dose-response curves for the 
effects of insulin with and without H-ISP. Adipose 
tissue exptants were incubated with the indicated wncen- 
Erations of insulin alone (0), or with H-ISP (15 @g/ml) 
(e). Values are means for duplicate determinations in 
two separate xperiments. 
Table 1 
Effect of H-ISP on CO2 liberation from glucose by rat 
adipocytes 
Insulin H-ISP “C02 liberated from D- 
@U/ml) (10 pg/ml) [l-‘4C]giucose (nmol/106 cells 
per h) 
Total Insulin- 
stimulated 
0 9.93 + 0.31 
+ 9.90 + 1.13 
5 16.62 + 2.46 6.69 
+ 22.87 + 3.71 12.97 
10 - 
+ 
29.70 f 3.77 19.77 
39.42 * 3.70 29.52 
30 52.29 t 1.88 42.36 
+ 69.81 * 5.44 59.91 
100 53.50 f 2.36 43.57 
+ 72.29 f 6.90 62.39 
Experimental conditions were as described in the text. 
Values are means f SE (n = 4) 
production from [l-‘4C]glucose by isolated rat 
adipocytes in the presence of suboptimal concen- 
trations of insulin. Again, H-ISP had no effect in 
the absence of added insulin, but significantly in- 
creased the maximal response to insulin to about 
140% of the maximal value obtained with insulin- 
alone (100 ,&/ml) (table 1). 
4. DISCUSSION 
This paper describes the presence of an insulin- 
stimulating principle, H-ISP, in human plasma for 
the first time. The results suggest hat H-ISP plays 
a role in controlling the insulin sensitivity and/or 
insulin responsiveness of target tissues. Authors in 
[ 121 reported that glucose ingestion was accom- 
panied by a marked increase in insulin sensitivity 
of human fat cells and they suggested that oral 
glucose stimulates the release of a circulatory fac- 
tor(s) that potentiates the insulin effect. Authors in 
[ 131 also observed an increase in insulin sensitivity 
of rat adipocytes after intravenous glucose infu- 
sion. However, little is known about the cellular 
processes that could enhance insulin sensitivity. 
Therefore, it might be of interest to examine the 
participation of H-ISP in these processes and also 
at the clinical level to investigate the relationship 
between H-ISP and the etiology of non-insulin- 
dependent diabetes mellitus. 
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